Home › NDC Lookup › Ingredients › Atorvastatin Calcium › 59651-0606-99
⚪image loading
(from DailyMed)

Atorvastatin Calcium 10 mg Tablet, Film Coated, 1,000-count — NDC 59651-606-99 (Billing 59651-0606-99)

by Aurobindo Pharma Limited · 1000 TABLET, FILM COATED in 1 BOTTLE

This is a package of 1,000 tablets of Atorvastatin Calcium 10 mg Tablet, Film Coated from Aurobindo Pharma Limited, marketed since Feb 2024 and currently FDA-listed; retail pharmacies pay about $0.0228 per tablet (NADAC). It is the main listing for this product, which comes in 5 package sizes.

NDC 59651-0606-99
🏷️ FDA NDC (as labeled) 59651-606-99 billing pads the product segment with a zero
This package
Contains1,000-count Cost per ea$0.0228 NADAC Per package$22.80 / 1000 tablets Pack sizes5 compare ↓
Also priced by: Medicaid pays $0.1829/unit · Part D plans $0.0927/unit — full pricing hub ↓
Main listing for product 59651-606 · Also comes in: 30 tablets 59651-606-30 90 tablets 59651-606-90 500 tablets 59651-606-05 120000 tablets 59651-606-12
On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Oct 1, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

⚠️
Other active recalls for Atorvastatin Calcium (different manufacturers) — 6 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Sep 19, 2025 — Failed Dissolution Specifications (Ascend Laboratories, LLC) · FDA recall D-0020-2026
Class II · Sep 19, 2025 — Failed Dissolution Specifications (Ascend Laboratories, LLC) · FDA recall D-0019-2026
Class II · Sep 19, 2025 — Failed Dissolution Specifications (Ascend Laboratories, LLC) · FDA recall D-0017-2026
Class II · Sep 19, 2025 — Failed Dissolution Specifications (Ascend Laboratories, LLC) · FDA recall D-0018-2026
Class II · Mar 17, 2025 — Failed dissolution specifications: lower than specifications (BIOCON PHARMA INC) · FDA recall D-0306-2025
Class II · Mar 16, 2023 — CGMP Deviations (Northwind Pharmaceuticals LLC) · FDA recall D-0548-2023
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 59651-606-99
Product NDC 59651-606
11-digit billing NDC 59651060699
NCPDP billing unit EA — each (per item)
SPL Set ID 80aead95-0fa8-4ef2-8d91-29c54d354823
DEA schedule Non-controlled
Marketing category DRUG FOR FURTHER PROCESSING
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2024-02-13
Dosage form TABLET, FILM COATED
Substance ATORVASTATIN CALCIUM TRIHYDRATE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 39400010100310
GCN Seq No 029967
GCN 43720
HICL code 012404
Ingredient (HICL) Atorvastatin Calcium
HIC1 code M
Therapeutic class — broad (HIC1) Blood
HIC2 code M4
Therapeutic class — intermediate (HIC2) Affect Blood Lipids/Sugar/Amino Acids
HIC3 code M4D
Therapeutic class — specific (HIC3) Antihyperlipidemic-Hmgcoa Reductase Inhib(Statins)
AHFS code 24:06.08.00
AHFS class Hmg-Coa Reductase Inhibitors
FDB label name ATORVASTATIN 10 MG TABLET
FDB brand name Atorvastatin Calcium
Legend status F — Federal legend — prescription drug or device
Quick answers
  • GSN (GCN sequence number): 029967
  • GCN: 43720
  • GPI-14 (Medi-Span): 39400010100310
  • HICL (First Databank): 012404
  • AHFS class code: 24:06.08.00
Why two NDCs? The FDA registers this code as 59651-606-99 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 59651-0606-99. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name ATORVASTATIN 10 MG TABLET Ingredient Atorvastatin Calcium
📗 Our plain-language guide HelloPharmacist
  • It lowers LDL cholesterol and triglycerides when used with diet. It also lowers the risk of heart attack and stroke in adults who have CHD or are at higher risk, including people w...
  • Take it by mouth once a day. Any time of day works, and you can take it with or without food. Pick a time you will remember. If you miss a dose, one label says to skip it and take...
  • Common ones include stuffy nose, joint or muscle aches, diarrhea, upset stomach, and trouble sleeping. Many people have few problems. If muscle pain is unexplained or comes with we...
  • Call for unexplained muscle pain, tenderness or weakness, especially with fever. Also call for yellow skin or eyes, or signs of a serious allergy like facial swelling or a blisteri...
📖 Read our full Atorvastatin guide →
2
Nutrient depletion considerations

Atorvastatin Calcium may be associated with lower levels of 2 nutrients — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Atorvastatin Calcium nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.023 $22.80 / 1000 tablets
Medicaid paysCMS SDUD · 12 mo $0.1829 $182.90 / 1000 tablets
Medicare drug plans payPart D · Q2 2026 $0.0927 $92.70 / 1000 tablets
NADAC price history (per ea) — tap or hover for the price & month
Dec 2025 Mar 2026 Jun 2026 Sep 2026 $0.026 $0.023
▼ Down 11% over the last 10 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
59651-0606-05 59651-606-05 500 TABLET, FILM COATED in 1 BOTTLE — — 2024-02-13 — Active
59651-0606-30 59651-606-30 30 TABLET, FILM COATED in 1 BOTTLE — — 2024-02-13 — Active
59651-0606-90 59651-606-90 90 TABLET, FILM COATED in 1 BOTTLE $0.0228 / ea $2.05 2024-02-13 — Active
59651-0606-99 You're viewing this Main listing 1000 TABLET, FILM COATED in 1 BOTTLE $0.0228 / ea $22.83 2024-02-13 — Active
59651-0606-12 59651-606-12 120000 TABLET, FILM COATED in 1 BAG — — — — Active

You're viewing one of 5 pack sizes for this product.

This pack effectively ties for the lowest per-ea cost of the 2 priced pack sizes ($0.0228 NADAC).

In Medicaid, this is the most-dispensed pack of this product — about 82% of fills over the last four reported quarters. See all packs ↓

Pack size FAQ

What quantity is in this package?
This is a 1,000-count package — 1000 tablet, film coated in 1 bottle.
How does this package differ from NDC 59651-0606-30?
Both are Atorvastatin Calcium 10 mg Tablet, Film Coated — the drug itself is identical. This page's package is the 1,000-count one, while NDC 59651-0606-30 is the 30 tablets package.
What NDC number is used to bill for this package of Atorvastatin Calcium 10 mg Tablet, Film Coated?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Atorvastatin Calcium 10 mg 00093-5056-10 Teva 1000 tablets $0.023 AB Availability likely —
Atorvastatin Calcium 10 mg 00378-3950-05 Mylan 500 tablets $0.023 AB Availability likely —
Atorvastatin Calcium 10 mg 00480-3585-10 Teva 1000 tablets $0.023 AB Availability likely —
Atorvastatin Calcium 10 mg 00904-6290-06 Major 1 tablet $0.023 AB Availability likely —
Atorvastatin Calcium 10 mg 16571-0136-09 Rising 90 tablets $0.023 AB Availability likely —
Atorvastatin Calcium 10 mg 31722-0424-05 Camber 500 tablets $0.023 AB Availability likely —
Atorvastatin calcium 10 mg 33342-0315-10 Macleods 90 tablets $0.023 AB Availability likely —
Atorvastatin Calcium 10 mg 42385-0940-01 Laurus 100 tablets $0.023 AB Availability likely —
Atorvastatin Calcium 10 mg 42571-0172-10 Micro 1000 tablets $0.023 AB Discontinued —
Atorvastatin Calcium 10 mg 43598-0098-05 Dr. 500 tablets $0.023 AB Availability likely —
Atorvastatin Calcium 10 mg 43598-0830-05 Dr. 500 tablets $0.023 AB Availability likely —
Atorvastatin Calcium 10 mg 50228-0451-10 ScieGen 1000 tablets $0.023 AB Availability likely —
Atorvastatin Calcium 10 mg 50268-0093-15 AvPAK 1 tablet $0.023 AB Availability likely —
Atorvastatin Calcium 10 mg 51079-0208-20 Mylan 1 tablet $0.023 AB Availability likely —
Atorvastatin Calcium 10 mg 55111-0121-05 Dr. 500 tablets $0.023 AB Availability likely —
Atorvastatin Calcium 10 mgthis 59651-0606-99 Aurobindo 1000 tablets $0.023 — Availability likely —
Atorvastatin Calcium 10 mg 67877-0511-05 Ascend 500 tablets $0.023 AB Availability likely —
Atorvastatin Calcium 10 mg 68084-0097-01 American 1 tablet $0.023 AB Availability likely —
Atorvastatin Calcium 10 mg 70377-0077-11 Biocon 90 tablets $0.023 AB Availability likely —
atorvastatin calcium 10 mg 70710-1777-00 Zydus 1000 tablets $0.023 AB Availability likely —
Atorvastatin calcium 10 mg 70756-0247-12 Lifestar 1000 tablets $0.023 AB Availability likely —
Atorvastatin calcium 10 mg 72205-0022-05 Novadoz 500 tablets $0.023 AB Availability likely —
Atorvastatin Calcium 10 mg 72603-0282-01 NorthStar 90 tablets $0.023 AB Availability likely —
Atorvastatin calcium 10 mg 72603-0403-02 NorthStar 100 tablets $0.023 AB Availability likely —
Atorvastatin calcium 10 mg 75834-0255-01 NIVAGEN 1000 tablets $0.023 AB Availability likely —
Atorvastatin Calcium 10 mg 82009-0001-10 Quallent 1000 tablets $0.023 AB Availability likely —
Atorvastatin Calcium 10 mg 82009-0176-10 Quallent 1000 tablets $0.023 AB Availability likely —
Atorvastatin Calcium 10 mg 16714-0173-01 NORTHSTAR 90 tablets $0.023 AB Discontinued +2%
Atorvastatin Calcium 10 mg 16729-0044-15 Accord 90 tablets $0.030 AB FDA listed +32%
Atorvastatin Calcium 10 mg 69097-0944-05 Cipla 90 tablets $0.030 AB FDA listed +32%
Atorvastatin Calcium 10 mg 68180-0635-02 Lupin 500 tablets $0.030 — Discontinued +32%
Lipitor 10 mg 58151-0155-77 Viatris 90 tablets $13.408 AB Availability likely +58631%
Atorvastatin Calcium 10 mg 00615-8006-05 NCS 15 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 42708-0003-30 QPharma, 30 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 42708-0014-30 QPharma, 30 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 43063-0474-30 PD-Rx 30 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 48433-0007-20 Safecor 1 tablet — AB FDA listed —
Atorvastatin Calcium 10 mg 50090-5184-00 A-S 30 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 50090-5636-00 A-S 30 tablets — — FDA listed —
Atorvastatin Calcium 10 mg 50090-6479-00 A-S 30 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 50090-6480-00 A-S 90 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 50090-7574-00 A-S 30 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 50090-7575-00 A-S 90 tablets — AB FDA listed —
atorvastatin calcium 10 mg 50090-7720-00 A-S 30 tablets — AB FDA listed —
atorvastatin calcium 10 mg 50090-7721-00 A-S 90 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 51655-0613-52 Northwind 30 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 51655-0946-52 Northwind 30 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 55154-5884-00 Cardinal 1 tablet — AB FDA listed —
Atorvastatin Calcium 10 mg 55154-6635-00 Cardinal 1 tablet — AB FDA listed —
Atorvastatin calcium 10 mg 60290-0039-01 Umedica 90 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 60505-2578-00 Apotex 10 tablets — AB FDA listed —
Atorvastatin calcium 10 mg 60760-0666-30 ST. 30 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 63629-8469-01 Bryant 90 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 67046-1442-03 Coupler 30 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 67046-1458-03 Coupler 30 tablets — AB FDA listed —
Atorvastatin calcium 10 mg 67046-1491-03 Coupler 30 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 67046-1677-03 Coupler 30 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 67296-2130-09 Redpharm 90 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 68071-2389-03 NuCare 30 tablets — AB FDA listed —
atorvastatin calcium 10 mg 68071-3546-09 NuCare 90 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 68071-3701-09 NuCare 90 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 68071-3813-03 NuCare 30 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 68071-3868-03 NuCare 30 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 68071-3912-09 NuCare 90 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 68071-5008-03 NuCare 30 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 68071-5198-03 NuCare 30 tablets — AB FDA listed —
Atorvastatin calcium 10 mg 68788-4008-01 Preferred 100 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 68788-8684-01 Preferred 100 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 68788-8842-03 Preferred 30 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 69097-0897-05 Cipla 90 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 70518-0224-00 REMEDYREPACK 30 tablets — AB Discontinued —
Atorvastatin calcium 10 mg 70518-3298-00 REMEDYREPACK 30 tablets — AB Discontinued —
Atorvastatin Calcium 10 mg 70518-4138-00 REMEDYREPACK 90 tablets — AB FDA listed —
Atorvastatin calcium 10 mg 70518-4422-00 REMEDYREPACK 100 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 70518-4550-00 REMEDYREPACK 100 tablets — AB FDA listed —
atorvastatin calcium 10 mg 70771-1875-00 Zydus 1000 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 71205-0246-30 Proficient 30 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 71209-0090-04 Cadila 90 tablets — — FDA listed —
Atorvastatin Calcium 10 mg 71335-1388-01 Bryant 30 tablets — AB Discontinued —
Atorvastatin Calcium 10 mg 71335-1710-01 Bryant 30 tablets — — FDA listed —
Atorvastatin Calcium 10 mg 71335-2241-01 Bryant 30 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 71335-2388-01 Bryant 30 tablets — AB FDA listed —
Atorvastatin calcium 10 mg 71335-2977-01 Bryant 30 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 71335-3144-01 Bryant 30 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 72162-1554-09 Bryant 90 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 72189-0226-30 DIRECT 30 tablets — — FDA listed —
Atorvastatin Calcium 10 mg 72189-0531-90 Direct_Rx 90 tablets — AB FDA listed —
Atorvastatin calcium 10 mg 72789-0153-30 PD-Rx 30 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 76420-0943-00 Asclemed 1000 tablets — AB FDA listed —
Atorvastatin Calcium 10 mg 77771-0451-10 Radha 1000 tablets — AB FDA listed —
atorvastatin calcium 10 mg 82137-0016-01 Lepu 90 tablets — — FDA listed —
Atorvastatin Calcium 10 mg 82804-0144-30 Proficient 30 tablets — AB FDA listed —
atorvastatin calcium 10 mg 65427-0155-10 Pfizer 160 tablets — — FDA listed —
atorvastatin calcium 10 mg 65427-0255-10 Pfizer 160 tablets — — FDA listed —
Atorvastatin Calcium 10 mg 72189-0681-30 Direct_Rx 30 tablets — AB FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2024
On the market since
Feb 2024
📍
2026
Currently FDA-listed
2 years listed
🔓
·
Generic versions listed
see equivalents
✅Generic appears available

FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerAurobindo Pharma Limited
Labeler code59651
First marketedFeb 2024
Product typeDrug For Further Processing
Portfolio1,456 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full FDA label FDA SPL

The complete FDA label for this product, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q2 2025 – Q1 2026 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
7.3K
Units reimbursed last 4 qtrs
329.7K
Gross reimbursed last 4 qtrs
$60.3K
Avg / prescription
$8.25
Avg / unit
$0.1829
Latest quarter Q1 2026
3.5KRx
Medicaid pays / ea
$0.1829
gross reimbursed
vs
NADAC / ea
$0.0228
acquisition cost
=
Spread
+$0.1601
+702% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
45% FFS 55% MCO
Fee-for-service · 3,291 Rx Managed care · 4,018 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: 10,746 units · 138 per 100k residents WA Idaho: 1,110 units · 56.5 per 100k residents ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 5,940 units · 104 per 100k residents MN Wisconsin: 3,447 units · 58.3 per 100k residents WI Michigan: 27,035 units · 269 per 100k residents MI New York: 85,610 units · 437 per 100k residents NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: 12,738 units · 301 per 100k residents OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: 6,954 units · 217 per 100k residents IA Illinois: 7,264 units · 57.9 per 100k residents IL Indiana: 5,951 units · 86.7 per 100k residents IN Ohio: 12,546 units · 106 per 100k residents OH Pennsylvania: 13,049 units · 101 per 100k residents PA New Jersey: 15,902 units · 171 per 100k residents NJ Massachusetts: 900 units · 12.9 per 100k residents MA California: 30,269 units · 77.7 per 100k residents CA Utah: 600 units · 17.6 per 100k residents UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: 3,810 units · 61.5 per 100k residents MO Kentucky: 2,370 units · 52.4 per 100k residents KY West Virginia: 510 units · 28.8 per 100k residents WV Virginia: 5,164 units · 59.2 per 100k residents VA Maryland: 2,149 units · 34.8 per 100k residents MD Connecticut: 952 units · 26.3 per 100k residents CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: 2,100 units · 99.3 per 100k residents NM Kansas: no data reported KS Arkansas: 1,860 units · 60.6 per 100k residents AR Tennessee: 6,418 units · 90.1 per 100k residents TN North Carolina: 16,661 units · 154 per 100k residents NC South Carolina: 3,630 units · 67.6 per 100k residents SC Delaware: no data reported DE Oklahoma: 3,860 units · 95.2 per 100k residents OK Louisiana: 1,590 units · 34.8 per 100k residents LA Mississippi: 994 units · 33.8 per 100k residents MS Alabama: 3,180 units · 62.3 per 100k residents AL Georgia: 3,330 units · 30.2 per 100k residents GA D.C.: no data reported DC Hawaii: no data reported HI Texas: 3,482 units · 11.4 per 100k residents TX Florida: 17,142 units · 75.8 per 100k residents FL
Units reimbursed · per 100k residents
11.4437
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 New York 437 /100k
2 Oregon 301 /100k
3 Michigan 269 /100k
4 Iowa 217 /100k
5 New Jersey 171 /100k
6 North Carolina 154 /100k
7 Washington 138 /100k
8 Ohio 106 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
1000 tablets this page59651-0606-99 7,309 Rx · $60,284
90 tablets59651-0606-90 1,648 Rx · $7,667
500 tablets59651-0606-05 No Medicaid data
30 tablets59651-0606-30 No Medicaid data
120000 tablets59651-0606-12 No Medicaid data
Drug total (last 4 qtrs): 8,957 Rx · 401,181 units · $67,951 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Atorvastatin Calcium (matched by generic name) — the program that covers self-administered drugs. 26 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Atorvastatin Calcium. CMS lists 3 products for this generic; we show the highest-spend one. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$194.53M
Claims incl. refills
18.7M
Beneficiaries
14.7M
Spend / beneficiary
$13.26
Spend / claim
$10.38
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

About this NDC listing & data coverage

Listed for further processing / repackaging

What "drug for further processing" means

FDA lists this package under the "drug for further processing" marketing category: Aurobindo Pharma Limited supplies it to other companies for further processing or repackaging (blister cards that are later repackaged or co-packaged are a common example). The units themselves are a finished dosage form — which is why pricing or Medicaid data can still appear — but this exact package code may not be the presentation a retail pharmacy dispenses.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) ✓ Available
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) ✓ Available
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Drug For Further Processing". Products approved under an application carry an NDA, ANDA, or BLA number.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Aurobindo Pharma Limited. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 4 other package presentations of this same product, including 30 tablets (59651-0606-30), 90 tablets (59651-0606-90), 500 tablets (59651-0606-05). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Aurobindo Pharma Limited is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 59651-0605-37 · Aurobindo 59651-0607-60 · Aurobindo →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.